The rise of cell therapy trials for stroke: Review of published and registered studies

Stem Cells and Development

Volumn 22, Issue 15, 2013, Pages 2095-2111

  Rosado De Castro, Paulo Henrique ^a   Pimentel Coelho, Pedro Moreno ^a   Da Fonseca, Lea Mirian Barbosa ^a   De Freitas, Gabriel Rodriguez ^a,b   Mendez Otero, Rosalia ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CYCLOSPORIN A; FLUORODEOXYGLUCOSE; NEUROTROPHIC FACTOR; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN;

APOPTOSIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BASAL GANGLION; BRAIN HEMORRHAGE; CELL DIFFERENTIATION; CELL MIGRATION; CELL SURVIVAL; CELL THERAPY; CEREBROVASCULAR ACCIDENT; CORD BLOOD STEM CELL TRANSPLANTATION; EMBRYONAL CARCINOMA STEM CELL; EPIGENETICS; FETAL PORCINE CELL TRANSPLANTATION; HEART INFARCTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; LATERAL BRAIN VENTRICLE; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; NUCLEAR REPROGRAMMING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; SUBVENTRICULAR ZONE; TERATOCARCINOMA; UMBILICAL CORD BLOOD;

ANIMALS; BONE MARROW TRANSPLANTATION; CLINICAL TRIALS AS TOPIC; CORD BLOOD STEM CELL TRANSPLANTATION; HUMANS; INJECTIONS, INTRA-ARTERIAL; INJECTIONS, INTRAVENTRICULAR; INJECTIONS, SPINAL; MESENCHYMAL STEM CELL TRANSPLANTATION; NEURAL STEM CELLS; STROKE;

EID: 84879793490     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2013.0089     Document Type: Review

References (135)

1. Lozano R, M Naghavi, K Foreman, S Lim, K Shibuya, V Aboyans, J Abraham, T Adair, R Aggarwal, et al. (2013). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095-2128.
2. Donnan GA, M Fisher, M Macleod and SM Davis. (2008). Stroke. Lancet 371:1612-1623.
3. Strong K, C Mathers and R Bonita. (2007). Preventing stroke: saving lives around the world. Lancet Neurol 6:182-187.
4. Murray CJ, T Vos, R Lozano, M Naghavi, AD Flaxman, C Michaud, M Ezzati, K Shibuya, JA Salomon, et al. (2013). Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2197-2223.
5. Molina CA. (2011). Reperfusion therapies for acute ischemic stroke: current pharmacological and mechanical approaches. Stroke 42:S16-S19.
6. Hacke W, G Donnan, C Fieschi, M Kaste, R von Kummer, JP Broderick, T Brott, M Frankel, JC Grotta, et al. (2004). Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 363:768-774.
7. Hess DC and WD Hill. (2011). Cell therapy for ischaemic stroke. Cell Prolif 44 Suppl 1:1-8.
8. Mendez-Otero R, GR de Freitas, C Andre, ML de Mendonca, M Friedrich and J Oliveira-Filho. (2007). Potential roles of bone marrow stem cells in stroke therapy. Regen Med 2:417-423.
9. Misra V, A Lal, R El Khoury, PR Chen and SI Savitz. (2012). Intra-arterial delivery of cell therapies for stroke. Stem Cells Dev 21:1007-1015.
10. Vahidy FS, S Alderman and SI Savitz. (2013). Challenges enrolling patients with acute ischemic stroke into cell therapy trials. Stem Cells Dev 22:27-30.
11. Thwaites JW, V Reebye, P Mintz, N Levicar and N Habib. (2012). Cellular replacement and regenerative medicine therapies in ischemic stroke. Regen Med 7:387-395.
12. Glover LE, N Tajiri, NL Weinbren, H Ishikawa, K Shinozuka, Y Kaneko, DM Watterson and CV Borlongan. (2012). A step-up approach for cell therapy in stroke: translational hurdles of bone marrow-derived stem cells. Transl Stroke Res 3:90-98.
13. Lindvall O and Z Kokaia. (2011). Stem cell research in stroke: how far from the clinic? Stroke 42:2369-2375.
14. Kukekov VG, ED Laywell, O Suslov, K Davies, B Scheffler, LB Thomas, TF O'Brien, M Kusakabe and DA Steindler. (1999). Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp Neurol 156:333-344.
15. Sanai N, AD Tramontin, A Quinones-Hinojosa, NM Barbaro, N Gupta, S Kunwar, MT Lawton, MW McDermott, AT Parsa, et al. (2004). Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427:740-744.
16. Azevedo-Pereira RL, E Medei, R Mendez-Otero, JP Souza and SV Alves-Leon. (2010). Isolation of neurosphere-like bodies from an adult patient with refractory temporal lobe epilepsy. Arq Neuropsiquiatr 68:956-958.
17. Lindvall O and Z Kokaia. (2009). Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease. Trends Pharmacol Sci 30:260-267.
18. Liu F, Y You, X Li, T Ma, Y Nie, B Wei, T Li, H Lin and Z Yang. (2009). Brain injury does not alter the intrinsic differentiation potential of adult neuroblasts. J Neurosci 29:5075-5087.
19. Seminatore C, J Polentes, D Ellman, N Kozubenko, V Itier, S Tine, L Tritschler, M Brenot, E Guidou, et al. (2010). The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 41:153-159.
20. Zhao T, ZN Zhang, Z Rong and Y Xu. (2011). Immunogenicity of induced pluripotent stem cells. Nature 474:212-215.
21. Araki R, M Uda, Y Hoki, M Sunayama, M Nakamura, S Ando, M Sugiura, H Ideno, A Shimada, A Nifuji and M Abe. (2013). Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494:100-104.
22. Fairchild PJ. (2010). The challenge of immunogenicity in the quest for induced pluripotency.Nat Rev Immunol 10:868-875.
23. Vierbuchen T, A Ostermeier, ZP Pang, Y Kokubu, TC Sudhof and M Wernig. (2010). Direct conversion of fibroblasts to functional neurons by defined factors. Nature 463:1035-1041.
24. Han DW, N Tapia, A Hermann, K Hemmer, S Hoing, MJ Arauzo-Bravo, H Zaehres, G Wu, S Frank, et al. (2012). Direct reprogramming of fibroblasts into neural stem cells by defined factors. Cell Stem Cell 10:465-472.
25. Lujan E, S Chanda, H Ahlenius, TC Sudhof and M Wernig. (2012). Direct conversion of mouse fibroblasts to selfrenewing, tripotent neural precursor cells. Proc Natl Acad Sci (USA) 109:2527-2532.
26. Kondziolka D, L Wechsler, S Goldstein, C Meltzer, KR Thulborn, J Gebel, P Jannetta, S DeCesare, EM Elder, et al. (2000). Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55:565-569.
27. Newman MB, I Misiuta, AE Willing, T Zigova, RC Karl, CV Borlongan and PR Sanberg. (2005). Tumorigenicity issues of embryonic carcinoma-derived stem cells: relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev 14:29-43.
28. Nelson PT, D Kondziolka, L Wechsler, S Goldstein, J Gebel, S DeCesare, EM Elder, PJ Zhang, A Jacobs, et al. (2002). Clonal human (hNT) neuron grafts for stroke therapy: neuropathology in a patient 27 months after implantation. Am J Pathol 160:1201-1206.
29. Kondziolka D, GK Steinberg, L Wechsler, CC Meltzer, E Elder, J Gebel, S Decesare, T Jovin, R Zafonte, et al. (2005). Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 103:38-45.
30. Meltzer CC, D Kondziolka, VL Villemagne, L Wechsler, S Goldstein, KR Thulborn, J Gebel, EM Elder, S DeCesare and A Jacobs. (2001). Serial [18F] fluorodeoxyglucose positron emission tomography after human neuronal implantation for stroke. Neurosurgery 49:586-591; discussion 591-582.
31. Pimentel-Coelho PM, PH Rosado-de-Castro, LM da Fonseca and R Mendez-Otero. (2012). Umbilical cord blood mononuclear cell transplantation for neonatal hypoxicischemic encephalopathy. Pediatr Res 71:464-473.
32. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
33. Zhang X, M Hirai, S Cantero, R Ciubotariu, L Dobrila, A Hirsh, K Igura, H Satoh, I Yokomi, et al. (2011). Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 112:1206-1218.
34. Guzman R, N Uchida, TM Bliss, D He, KK Christopherson, D Stellwagen, A Capela, J Greve, RC Malenka, et al. (2007). Long-term monitoring of transplanted human neural stem cells in developmental and pathological contexts with MRI. Proc Natl Acad Sci (USA) 104:10211-10216.
35. Daadi MM, Z Li, A Arac, BA Grueter, M Sofilos, RC Malenka, JC Wu and GK Steinberg. (2009). Molecular and magnetic resonance imaging of human embryonic stem cell-derived neural stem cell grafts in ischemic rat brain. Mol Ther 17:1282-1291.
36. Lopez-Bendito G and P Arlotta. (2012). Cell replacement therapies for nervous system regeneration. Dev Neurobiol 72:145-152.
37. Lu P, LL Jones, EY Snyder and MH Tuszynski. (2003). Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181:115-129.
38. Andres RH, N Horie, W Slikker, H Keren-Gill, K Zhan, G Sun, NC Manley, MP Pereira, LA Sheikh, et al. (2011). Human neural stem cells enhance structural plasticity and axonal transport in the ischaemic brain. Brain 134:1777-1789.
39. Hawryluk GW, AJ Mothe, M Chamankhah, J Wang, C Tator and MG Fehlings. (2012). In vitro characterization of trophic factor expression in neural precursor cells. Stem Cells Dev 21:432-447.
40. Horie N, MP Pereira, K Niizuma, G Sun, H Keren-Gill, A Encarnacion, M Shamloo, SA Hamilton, K Jiang, et al. (2011). Transplanted stem cell-secreted VEGF effects poststroke recovery, inflammation, and vascular repair. Stem Cells 29:274-285.
41. Mosher KI, RH Andres, T Fukuhara, G Bieri, M Hasegawa-Moriyama, Y He, R Guzman and T Wyss-Coray. (2012). Neural progenitor cells regulate microglia functions and activity. Nat Neurosci 15:1485-1487.
42. Bacigaluppi M, S Pluchino, L Peruzzotti-Jametti, E Kilic, U Kilic, G Salani, E Brambilla, MJ West, G Comi, G Martino and DM Hermann. (2009). Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 132:2239-2251.
43. Guzman R, A De Los Angeles, S Cheshier, R Choi, S Hoang, J Liauw, B Schaar and G Steinberg. (2008). Intracarotid injection of fluorescence activated cell-sorted CD49d-positive neural stem cells improves targeted cell delivery and behavior after stroke in a mouse stroke model. Stroke 39:1300-1306.
44. Smith EJ, RP Stroemer, N Gorenkova, M Nakajima, WR Crum, E Tang, L Stevanato, JD Sinden and M Modo. (2012). Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke. Stem Cells 30:785-796.
45. Andres RH, R Choi, AV Pendharkar, X Gaeta, N Wang, JK Nathan, JY Chua, SW Lee, TD Palmer, GK Steinberg and R Guzman. (2011). The CCR2/CCL2 interaction mediates the transendothelial recruitment of intravascularly delivered neural stem cells to the ischemic brain. Stroke 42:2923-2931.
46. Lee ST, K Chu, KH Jung, SJ Kim, DH Kim, KM Kang, NH Hong, JH Kim, JJ Ban, et al. (2008). Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 131:616-629.
47. Park DH, DJ Eve, PR Sanberg, J Musso,AD Bachstetter, A Wolfson, A Schlunk, MO Baradez, JD Sinden and C Gemma. (2010). Increased neuronal proliferation in the dentate gyrus of aged rats following neural stem cell implantation. Stem Cells Dev 19:175-180.
48. Roybon L, Z Ma, F Asztely, A Fosum, SE Jacobsen, P Brundin and JY Li. (2006). Failure of transdifferentiation of adult hematopoietic stem cells into neurons. Stem Cells 24:1594-1604.
49. Barnabe GF, TT Schwindt, ME Calcagnotto, FL Motta, G Martinez, Jr., AC de Oliveira, LM Keim, V D'Almeida, R Mendez-Otero and LE Mello. (2009). Chemically-induced RAT mesenchymal stem cells adopt molecular properties of neuronal-like cells but do not have basic neuronal functional properties. PLoS One 4:e5222.
50. Vallieres L and PE Sawchenko. (2003). Bone marrowderived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 23:5197-5207.
51. Schwarting S, S Litwak, W Hao, M Bahr, J Weise and H Neumann. (2008). Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 39:2867-2875.
52. Mitkari B, E Kerkela, J Nystedt, M Korhonen, V Mikkonen, T Huhtala and J Jolkkonen. (2012). Intra-arterial infusion of human bone marrow-derived mesenchymal stem cells results in transient localization in the brain after cerebral ischemia in rats. Exp Neurol 239:158-162.
53. Borlongan CV, M Hadman, CD Sanberg and PR Sanberg. (2004). Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 35:2385-2389.
54. Vendrame M, C Gemma, D de Mesquita, L Collier, PC Bickford, CD Sanberg, PR Sanberg, KR Pennypacker and AE Willing. (2005). Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14:595-604.
55. Vendrame M, C Gemma, KR Pennypacker, PC Bickford, C Davis Sanberg, PR Sanberg and AE Willing. (2006). Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol 199:191-200.
56. Ohtaki H, JH Ylostalo, JE Foraker, AP Robinson, RL Reger, S Shioda and DJ Prockop. (2008). Stem/progenitor cells from bone marrow decrease neuronal death in global ischemia by modulation of inflammatory/immune responses. Proc Natl Acad Sci (USA) 105:14638-14643.
57. Giraldi-Guimaraes A, M Rezende-Lima, FP Bruno and R Mendez-Otero. (2009). Treatment with bone marrow mononuclear cells induces functional recovery and decreases neurodegeneration after sensorimotor cortical ischemia in rats. Brain Res 1266:108-120.
58. Chopp M, Y Li and ZG Zhang. (2009). Mechanisms underlying improved recovery of neurological function after stroke in the rodent after treatment with neurorestorative cell-based therapies. Stroke 40:S143-S145.
59. Vasconcelosde Dos Santos A, J da Costa Reis, B Diaz Paredes, L Moraes, Jasmin, A Giraldi-Guimaraes and R Mendez-Otero. (2010). Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res 1306:149-158.
60. Brenneman M, S Sharma, M Harting, R Strong, CS Cox, Jr., J Aronowski, JC Grotta and SI Savitz. (2010). Autologous bone marrow mononuclear cells enhance recovery after acute ischemic stroke in young and middle-aged rats. J Cereb Blood Flow Metab 30:140-149.
61. Yasuhara T, N Matsukawa, K Hara, M Maki, MM Ali, SJ Yu, E Bae, G Yu, L Xu, et al. (2009). Notch-induced rat and human bone marrow stromal cell grafts reduce ischemic cell loss and ameliorate behavioral deficits in chronic stroke animals. Stem Cells Dev 18:1501-1514.
62. Xiao J, Z Nan, Y Motooka and WC Low. (2005). Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells Dev 14:722-733.
63. Newman MB, AE Willing, JJ Manresa, C Davis-Sanberg and PR Sanberg. (2005). Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. Stem Cells Dev 14:576-586.
64. Bakondi B, IS Shimada, BM Peterson and JL Spees. (2011). SDF-1alpha secreted by human CD133-derived multipotent stromal cells promotes neural progenitor cell survival through CXCR7. Stem Cells Dev 20:1021-1029.
65. Taguchi A, T Soma, H Tanaka, T Kanda, H Nishimura, H Yoshikawa, Y Tsukamoto, H Iso, Y Fujimori, et al. (2004). Administration of CD34 + cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114:330-338.
66. Bao X, M Feng, J Wei, Q Han, H Zhao, G Li, Z Zhu, H Xing, Y An, et al. (2011). Transplantation of Flk-1 + human bone marrow-derived mesenchymal stem cells promotes angiogenesis and neurogenesis after cerebral ischemia in rats. Eur J Neurosci 34:87-98.
67. Goldman SA and Z Chen. (2011). Perivascular instruction of cell genesis and fate in the adult brain. Nat Neurosci 14:1382-1389.
68. Lin YC, TL Ko, YH Shih, MY Lin, TW Fu, HS Hsiao, JY Hsu and YS Fu. (2011). Human umbilical mesenchymal stem cells promote recovery after ischemic stroke. Stroke 42:2045-2053.
69. Ranganath SH, O Levy, MS Inamdar and JM Karp. (2012). Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease. Cell Stem Cell 10: 244-258.
70. Xin H, Y Li, B Buller, M Katakowski, Y Zhang, X Wang, X Shang, ZG Zhang and M Chopp. (2012). Exosomemediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth. Stem Cells 30:1556-1564.
71. van Velthoven CT, A Kavelaars, F van Bel and CJ Heijnen. (2010). Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 30:9603-9611.
72. Yang B, X Xi, J Aronowski and SI Savitz. (2012). Ischemic stroke may activate bone marrow mononuclear cells to enhance recovery after stroke. Stem Cells Dev. 21:3332-3340.
73. Fan Y, F Shen, T Frenzel, W Zhu, J Ye, J Liu, Y Chen, H Su, WL Young and GY Yang. (2010). Endothelial progenitor cell transplantation improves long-term stroke outcome in mice. Ann Neurol 67:488-497.
74. Nih LR, N Deroide, C Lere-Dean, D Lerouet, M Soustrat, BI Levy, JS Silvestre, T Merkulova-Rainon, M Pocard, I Margaill and N Kubis. (2012). Neuroblast survival depends on mature vascular network formation after mouse stroke: role of endothelial and smooth muscle progenitor cell coadministration. Eur J Neurosci 35:1208-1217.
75. Zhang L, Y Li, C Zhang, M Chopp, A Gosiewska and K Hong. (2011). Delayed administration of human umbilical tissue-derived cells improved neurological functional recovery in a rodent model of focal ischemia. Stroke 42:1437-1444.
76. Savitz SI, J Dinsmore, J Wu, GV Henderson, P Stieg and LR Caplan. (2005). Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study. Cerebrovasc Dis 20:101-107.
77. Suarez-Monteagudo C, P Hernandez-Ramirez, L Alvarez-Gonzalez, I Garcia-Maeso, K de la Cuetara-Bernal, L Castillo-Diaz, ML Bringas-Vega, G Martinez-Aching, LM Morales-Chacon, et al. (2009). Autologous bone marrow stem cell neurotransplantation in stroke patients. An open study. Restor Neurol Neurosci 27:151-161.
78. Bringas ML, C Suarez, C Sanchez, LM Alvarez, P Valdes, S Salazar, D Chongo and M Jahanshahi. (2011). Cognitive changes after stem cell transplantation in a patient with subcortical stroke. BMJ Case Rep. DOI: http://dx.doi.org/10.1136/bcr.03.2011.3944.
79. Li ZM, ZT Zhang, CJ Guo, FY Geng, F Qiang and LX Wang. (2013). Autologous bone marrow mononuclear cell implantation for intracerebral hemorrhage-A prospective clinical observation. Clin Neurol Neurosurg 115:72-76.
80. Rabinovich SS, VI Seledtsov, NV Banul, OV Poveshchenko, VV Senyukov, SV Astrakov, DM Samarin and VY Taraban. (2005). Cell therapy of brain stroke. Bull Exp Biol Med 139:126-128.
81. Sharma A, H Sane, P Badhe, P Kulkarni, G Chopra, M Lohia and N Gokulchandran. (2012). Autologous bone marrow stem cell therapy shows functional improvement in hemorrhagic stroke. Indian J Clin Pract 23:100-105.
82. Han H, SK Chang, JJ Chang, SH Hwang, SH Han and BH Chun. (2011). Intrathecal injection of human umbilical cord blood-derived mesenchymal stem cells for the treatment of basilar artery dissection: a case report. J Med Case Rep 5:562.
83. Correa P, R Felix, ML Mendonca, G Freitas, J Azevedo, H Dohmann, S Alves and C Mesquita. (2005). Dual-head coincidence gamma camera FDG-PET before and after autologous bone marrow mononuclear cell implantation in ischaemic stroke. Eur J Nucl Med Mol Imaging 32: 999.
84. Mendonca ML, GR Freitas, SA Silva, A Manfrim, CH Falcao, C Gonzales, C Andre, HF Dohmann, R Borojevic and RM Otero. (2006). [Safety of intra-arterial autologous bone marrow mononuclear cell transplantation for acute ischemic stroke]. Arq Bras Cardiol 86:52-55.
85. Correa PL, CT Mesquita, RM Felix, JC Azevedo, GB Barbirato, CH Falcao, C Gonzalez, ML Mendonca, A Manfrim, et al. (2007). Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke. Clin Nucl Med 32:839-841.
86. Barbosada Fonseca LM, V Battistella, GR Freitasde, B Gutfilen, RC Dos Santos Goldenberg, A Maiolino, E Wajnberg, PH Rosado de Castro, R Mendez-Otero and C Andre. (2009). Early tissue distribution of bone marrow mononuclear cells after intra-arterial delivery in a patient with chronic stroke. Circulation 120:539-541.
87. Barbosada Fonseca LM, B Gutfilen, PH Rosadode Castro, V Battistella, RC Goldenberg, T Kasai-Brunswick, CL Chagas, E Wajnberg, A Maiolino, et al. (2010). Migration and homing of bone-marrow mononuclear cells in chronic ischemic stroke after intra-arterial injection. Exp Neurol 221:122-128.
88. Battistella V, GR de Freitas, LM da Fonseca, D Mercante, B Gutfilen, RC Goldenberg, JV Dias, TH Kasai-Brunswick, E Wajnberg, et al. (2011). Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med 6:45-52.
89. Rosado de Castro PH, FR Schmidt, V Battistella, SA Lopes de Souza, B Gutfilen, RC Goldenberg, TH Kasai-Brunswick, L Vairo, RM Silva, et al. (2013). Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients. Regen Med 8:145-155.
90. Friedrich MA, MP Martins, MD Araujo, C Klamt, L Vedolin, B Garicochea, EF Raupp, JS Ammar, DC Machado, et al. (2012). Intra-arterial infusion of autologous bonemarrow mononuclear cells in patients with moderate to severe middle-cerebral-artery acute ischemic stroke. Cell Transplant 21:S13-S21.
91. Moniche F, A Gonzalez, JR Gonzalez-Marcos, M Carmona, P Pinero, I Espigado, D Garcia-Solis, A Cayuela, J Montaner, et al. (2012). Intra-arterial bone marrow mononuclear cells in ischemic stroke: a pilot clinical trial. Stroke 43:2242-2244.
92. Jiang Y, W Zhu, J Zhu, L Wu, G Xu and X Liu. (2012). Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of lesion artery in patients with stroke in the territory of middle cerebral artery. Cell Transplant. [Epub ahead of print]; DOI: 10.3727/096368912X658818.
93. Man Y, J Li, B Yang and J Ma. (2006). Vein transplantation using human umbilical cord blood stem cells in the treatment of stroke sequela. Neural Regen Res 1:618-621.
94. Bang OY, JS Lee, PH Lee and G Lee. (2005). Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874-882.
95. Lee JS, JM Hong, GJ Moon, PH Lee, YH Ahn, OY Bang and S collaborators. (2010). A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke. Stem Cells 28:1099-1106.
96. Honmou O, K Houkin, T Matsunaga, Y Niitsu, S Ishiai, R Onodera, SG Waxman and JD Kocsis. (2011). Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke. Brain 134:1790-1807.
97. Bhasin A, MV Srivastava, SS Kumaran, S Mohanty, R Bhatia, S Bose, S Gaikwad, A Garg and B Airan. (2011). Autologous mesenchymal stem cells in chronic stroke. Cerebrovasc Dis Extra 1:93-104.
98. Savitz SI, V Misra, M Kasam, H Juneja, CS Cox, Jr., S Alderman, I Aisiku, S Kar, A Gee and JC Grotta. (2011). Intravenous autologous bone marrow mononuclear cells for ischemic stroke. Ann Neurol 70:59-69.
99. Prasad K, S Mohanty, R Bhatia, MV Srivastava, A Garg, A Srivastava, V Goyal, M Tripathi, A Kumar, et al. (2012). Autologous intravenous bone marrow mononuclear cell therapy for patients with subacute ischaemic stroke: A pilot study. Indian J Med Res 136:221-228.
100. Bhasin A, MV Srivastava, R Bhatia, S Mohanty, SS Kumaran and S Bose. (2012a). Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke. J Stem Cells Regen Med 8:181-189.
101. Bhasin A, MV Padma Srivastava, S Mohanty, R Bhatia, SS Kumaran and S Bose. (2012b). Stem cell therapy: A clinical trial of stroke. Clin Neurol Neurosurg. In Press.
102. England TJ, M Abaei, DP Auer, J Lowe, DR Jones, G Sare, M Walker and PM Bath. (2012). Granulocyte-colony stimulating factor for mobilizing bone marrow stem cells in subacute stroke: the stem cell trial of recovery enhancement after stroke 2 randomized controlled trial. Stroke 43:405-411.
103. Bliss TM, RH Andres and GK Steinberg. (2010). Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 37:275-283.
104. Burt RK, Y Loh, W Pearce, N Beohar, WG Barr, R Craig, Y Wen, JA Rapp and J Kessler. (2008). Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 299:925-936.
105. Resnick IB, MY Shapira and S Slavin. (2005). Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Transpl Immunol 14:207-219.
106. Jeevanantham V, M Butler, A Saad, A Abdel-Latif, EK Zuba-Surma and B Dawn. (2012). Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 126:551-568.
107. Hare JM, JE Fishman, G Gerstenblith, DL Difede Velazquez, JP Zambrano, VY Suncion, M Tracy, E Ghersin, PV Johnston, et al. (2012). Comparison of Allogeneic vs Autologous Bone Marrow-Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy: The POSEIDON Randomized Trial. JAMA:1-11.
108. Fadini GP, C Agostini and A Avogaro. (2010). Autologous stem cell therapy for peripheral arterial disease metaanalysis and systematic review of the literature. Atherosclerosis 209:10-17.
109. Lees JS, ES Sena, KJ Egan, A Antonic, SA Koblar, DW Howells and MR Macleod. (2012). Stem cell-based therapy for experimental stroke: a systematic review and metaanalysis. Int J Stroke 7:582-588.
110. Iadecola C and J Anrather. (2011). The immunology of stroke: from mechanisms to translation. Nat Med 17:796-808.
111. Imitola J, K Raddassi, KI Park, FJ Mueller, M Nieto, YD Teng, D Frenkel, J Li, RL Sidman, et al. (2004). Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. Proc Natl Acad Sci (USA) 101:18117-18122.
112. Wang Y, Y Deng and GQ Zhou. (2008). SDF-1alpha/CXCR4-mediated migration of systemically transplanted bone marrow stromal cells towards ischemic brain lesion in a rat model. Brain Res 1195:104-112.
113. Abarbanell AM, Y Wang, JL Herrmann, BR Weil, JA Poynter, MC Manukyan and DR Meldrum. (2010). Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 298:H1529-1536.
114. Mine Y, J Tatarishvili, K Oki, E Monni, Z Kokaia and O Lindvall. (2013). Grafted human neural stem cells enhance several steps of endogenous neurogenesis and improve behavioral recovery after middle cerebral artery occlusion in rats. Neurobiol Dis 52:191-203.
115. Oki K, J Tatarishvili, J Wood, P Koch, S Wattananit, Y Mine, E Monni, D Tornero, H Ahlenius, et al. (2012). Humaninduced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells 30:1120-1133.
116. Sakata H, P Narasimhan, K Niizuma, CM Maier, T Wakai and PH Chan. (2012). Interleukin 6-preconditioned neural stem cells reduce ischaemic injury in stroke mice. Brain 135:3298-3310.
117. Yang B, R Strong, S Sharma, M Brenneman, K Mallikarjunarao, X Xi, JC Grotta, J Aronowski and SI Savitz. (2011). Therapeutic time window and dose response of autologous bone marrow mononuclear cells for ischemic stroke. J Neurosci Res 89:833-839.
118. Komatsu K, O Honmou, J Suzuki, K Houkin, H Hamada and JD Kocsis. (2010). Therapeutic time window of mesenchymal stem cells derived from bone marrow after cerebral ischemia. Brain Res 1334:84-92.
119. Saporta S, CV Borlongan and PR Sanberg. (1999). Neural transplantation of human neuroteratocarcinoma (hNT) neurons into ischemic rats. A quantitative dose-response analysis of cell survival and behavioral recovery. Neuroscience 91:519-525.
120. Li L, Q Jiang, G Ding, L Zhang, ZG Zhang, Q Li, S Panda, M Lu, JR Ewing and M Chopp. (2010). Effects of administration route on migration and distribution of neural progenitor cells transplanted into rats with focal cerebral ischemia, an MRI study. J Cereb Blood Flow Metab 30:653-662.
121. Walczak P, J Zhang, AA Gilad, DA Kedziorek, J Ruiz-Cabello, RG Young, MF Pittenger, PC van Zijl, J Huang and JW Bulte. (2008). Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia. Stroke 39:1569-1574.
122. Kamiya N, M Ueda, H Igarashi, Y Nishiyama, S Suda, T Inaba and Y Katayama. (2008). Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci 83:433-437.
123. Vasconcelos-dos-Santos A, PH Rosado-de-Castro, SA Lopes de Souza, J da Costa Silva, AB Ramos, G Rodriguez de Freitas, LM Barbosa da Fonseca, B Gutfilen and R Mendez-Otero. (2012). Intravenous and intra-arterial administration of bone marrow mononuclear cells after focal cerebral ischemia: is there a difference in biodistribution and efficacy? Stem Cell Res 9:1-8.
124. Zhang L, Y Li, M Romanko, BC Kramer, A Gosiewska, M Chopp and K Hong. (2012). Different routes of administration of human umbilical tissue-derived cells improve functional recovery in the rat after focal cerebral ischemia. Brain Res 1489:104-112.
125. de Freitas GR and R Mendez-Otero. (2013). Intra-arterial Cell Therapy in Stroke Patients. In: Cell-Based Therapies in Stroke. Jolkkonen J, P Walczak, eds. Springer, New York, pp 181-190.
126. El Khoury R, V Misra, S Sharma, CS Cox, P Walker, JC Grotta, A Gee, S Suzuki and SI Savitz. (2010). The effect of transcatheter injections on cell viability and cytokine release of mononuclear cells. AJNR Am J Neuroradiol 31: 1488-1492.
127. Ben-David U, QF Gan, T Golan-Lev, P Arora, O Yanuka, YS Oren, A Leikin-Frenkel, M Graf, R Garippa, et al. (2013). Selective elimination of human pluripotent stem cells by an oleate synthesis inhibitor discovered in a high-throughput screen. Cell Stem Cell 12:167-179.
128. Chen J, X Ye, T Yan, C Zhang, XP Yang, X Cui, Y Cui, A Zacharek, C Roberts, et al. (2011). Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke 42:3551-3558.
129. Sprigg N, PM Bath, L Zhao, MR Willmot, LJ Gray, MF Walker, MS Dennis and N Russell. (2006). Granulocytecolony-stimulating factor mobilizes bone marrow stem cells in patients with subacute ischemic stroke: the Stem cell Trial of recovery EnhanceMent after Stroke (STEMS) pilot randomized, controlled trial (ISRCTN 16784092). Stroke 37:2979-2983.
130. Shyu WC, SZ Lin, CC Lee, DD Liu and H Li. (2006). Granulocyte colony-stimulating factor for acute ischemic stroke: a randomized controlled trial. CMAJ 174:927-933.
131. SchabitzWR, R Laage,GVogt,WKoch, R Kollmar, S Schwab, D Schneider, GF Hamann, M Rosenkranz, et al. (2010). AXIS: a trial of intravenous granulocyte colony-stimulating factor in acute ischemic stroke. Stroke 41:2545-2551.
132. Boy S, S Sauerbruch, M Kraemer, T Schormann, F Schlachetzki, G Schuierer, R Luerding, B Hennemann, E Orso, et al. (2011). Mobilisation of hematopoietic CD34 + precursor cells in patients with acute stroke is safe-results of an open-labeled non randomized phase I/II trial. PLoS One 6:e23099.
133. Floel A, T Warnecke, T Duning, Y Lating, J Uhlenbrock, A Schneider, G Vogt, R Laage, W Koch, S Knecht and WR Schabitz. (2011). Granulocyte-colony stimulating factor (G-CSF) in stroke patients with concomitant vascular disease-a randomized controlled trial. PLoS One 6:e19767.
134. Moriya Y, A Mizuma, T Uesugi, Y Ohnuki, E Nagata, W Takahashi, H Kobayashi, H Kawada, K Ando, S Takagi and S Takizawa. (2012). Phase I Study of intravenous low-dose granulocyte colony-stimulating factor in acute and subacute ischemic stroke. J Stroke Cerebrovasc Dis. [Epub ahead of print]; DOI: 10.1016/j.jstrokecerebrovasdis.2012.08.002.
135. Goldring CE, PA Duffy, N Benvenisty, PW Andrews, U Ben-David, R Eakins, N French, NA Hanley, L Kelly, et al. (2011). Assessing the safety of stem cell therapeutics. Cell Stem Cell 8:618-628.